2023. Humoral and cellular BNT162b2 mRNA-based booster vaccine-induced immunity in patients with multiple myeloma and persistence of neutralising antibodies: results of a prospective single-centre cohort study. Swiss Medical Weekly. 153, 6 (Jun. 2023), 40090. DOI:https://doi.org/10.57187/smw.2023.40090.